Cellular and Molecular Neurobiology

, Volume 39, Issue 1, pp 137–147 | Cite as

Rs7219 Regulates the Expression of GRB2 by Affecting miR-1288-Mediated Inhibition and Contributes to the Risk of Schizophrenia in the Chinese Han Population

  • Jialei Yang
  • Xiaojing Guo
  • Lulu Zhu
  • Jiao Huang
  • Jianxiong Long
  • Qiang Chen
  • Runde Pan
  • Zhaoxia Chen
  • Xulong Wu
  • Li SuEmail author
Original Research


In the present study, we examined a potential genetic association between the variant rs7219 within the 3′-UTR of GRB2 and the susceptibility to schizophrenia (SCZ) and bipolar disorder (BD) in the Chinese Han population. A genetic association study, including 548 SCZ patients, 512 BD patients, and 598 normal controls, was conducted in the Chinese Han population. Genotyping was performed through the Sequenom MassARRAY technology platform. The expression of GRB2 was detected using quantitative real-time polymerase chain reaction (qRT-PCR). A dual-luciferase reporter assay was performed to determine whether miR-1288 could bind to the 3′-UTR region of GRB2 containing rs7219. We found that rs7219 was significantly associated with the susceptibility to SCZ under different genetic models, including additive [OR (95% CI) = 1.24 (1.02–1.49), P = 0.027], dominant [OR (95% CI) = 1.31 (1.04–1.66), P = 0.025], and allelic models[OR (95% CI) = 1.24 (1.03–1.49), P = 0.027]. However, no significant associations were found between rs7219 and the risk for BD (all P > 0.05). Moreover, we observed that the expression of GRB2 significantly decreased in SCZ patients compared with the controls (P = 0.004). The dual-luciferase reporter assay showed that the minor allele C of rs7219 significantly decreased the luciferase activity by binding miR-1288 (P < 0.001). In summary, we are the first to reveal that rs7219 is significantly associated with the susceptibility to SCZ in the Chinese Han population. Moreover, the minor allele C of rs7219 is identified as a risk allele for SCZ because it generates a binding site for miR-1288, thereby resulting in decreased expression of GRB2 and ultimately increasing the risk of SCZ.


Rs7219 GRB2 Dual-luciferase reporter assay Schizophrenia Bipolar disorder 



This study was supported by the National Natural Science Foundation of China (Nos. 81460518 and 81573756) and the Science and Technology Program of Guangxi Colleges and Universities (KY2015YB062).

Author Contribution

Li Su designed the study protocol and conceived the framework of this article. Jialei Yang, Jiao Huang, Qiang Chen, and Runde Pan collected the study samples. Jialei Yang, Xiaojing Guo, Lulu Zhu, Jiao Huang, Zhaoxia Chen, and Xulong Wu performed experiments. Jiao Huang, Jianxiong Long, Zhaoxia Chen, and Xulong Wu undertook the statistical analysis. Jialei Yang, Xiaojing Guo, and Lulu Zhu wrote the first draft of this manuscript. All authors contributed to and have approved the final manuscript.

Compliance with Ethical Standards

Conflict of interest

All of authors declare that they have no financial or other conflict of interests.


  1. Adams JP, Sweatt JD (2002) Molecular psychology: roles for the ERK MAP kinase cascade in memory. Ann Rev Pharmacol Toxicol 42:135–163. Google Scholar
  2. Ament SA, Szelinger S, Glusman G, Ashworth J, Hou L, Akula N, Shekhtman T, Badner JA, Brunkow ME, Mauldin DE, Stittrich AB, Rouleau K, Detera-Wadleigh SD, Nurnberger JI Jr, Edenberg HJ, Gershon ES, Schork N, Bipolar Genome S, Price ND, Gelinas R, Hood L, Craig D, McMahon FJ, Kelsoe JR, Roach JC (2015) Rare variants in neuronal excitability genes influence risk for bipolar disorder. Proc Natl Acad Sci USA 112(11):3576–3581. Google Scholar
  3. Anderson KD, Alderson RF, Altar CA, DiStefano PS, Corcoran TL, Lindsay RM, Wiegand SJ (1995) Differential distribution of exogenous BDNF, NGF, and NT-3 in the brain corresponds to the relative abundance and distribution of high-affinity and low-affinity neurotrophin receptors. J Comp Neurol 357(2):296–317. Google Scholar
  4. Asada H, Ishii N, Sasaki Y, Endo K, Kasai H, Tanaka N, Takeshita T, Tsuchiya S, Konno T, Sugamura K (1999) Grf40, A novel Grb2 family member, is involved in T cell signaling through interaction with SLP-76 and LAT. J Exp Med 189(9):1383–1390Google Scholar
  5. Burmeister M, McInnis MG, Zollner S (2008) Psychiatric genetics: progress amid controversy. Nat RevGenet 9(7):527–540. Google Scholar
  6. Cardno AG, Gottesman II (2000) Twin studies of schizophrenia: from bow-and-arrow concordances to star wars Mx and functional genomics. Am J Med Genet 97(1):12–17Google Scholar
  7. Choo M, Miyazaki T, Yamazaki M, Kawamura M, Nakazawa T, Zhang J, Tanimura A, Uesaka N, Watanabe M, Sakimura K, Kano M (2017) Retrograde BDNF to TrkB signaling promotes synapse elimination in the developing cerebellum. Nat Commun 8(1):195. Google Scholar
  8. Clark SG, Stern MJ, Horvitz HR (1992) C. elegans cell-signalling gene sem-5 encodes a protein with SH2 and SH3 domains. Nature 356(6367):340–344. Google Scholar
  9. Colledge M, Froehner SC (1998) Interaction between the nicotinic acetylcholine receptor and Grb2. Implications for signaling at the neuromuscular junction. Ann N Y Acad Sci 841:17–27Google Scholar
  10. Craddock N, Jones I (1999) Genetics of bipolar disorder. J Med Genet 36(8):585–594Google Scholar
  11. Di Daniel E, Mudge AW, Maycox PR (2005) Comparative analysis of the effects of four mood stabilizers in SH-SY5Y cells and in primary neurons. Bipolar Disord 7(1):33–41. Google Scholar
  12. Djuranovic S, Nahvi A, Green R (2012) miRNA-mediated gene silencing by translational repression followed by mRNA deadenylation and decay. Science 336(6078):237–240. Google Scholar
  13. Durany N, Thome J (2004) Neurotrophic factors and the pathophysiology of schizophrenic psychoses. Eur Psychiat 19(6):326–337. Google Scholar
  14. Easton JB, Moody NM, Zhu X, Middlemas DS (1999) Brain-derived neurotrophic factor induces phosphorylation of fibroblast growth factor receptor substrate 2. J Biol Chem 274(16):11321–11327Google Scholar
  15. Egan SE, Giddings BW, Brooks MW, Buday L, Sizeland AM, Weinberg RA (1993) Association of Sos Ras exchange protein with Grb2 is implicated in tyrosine kinase signal transduction and transformation. Nature 363(6424):45–51. Google Scholar
  16. Feller SM, Lewitzky M (2006) Potential disease targets for drugs that disrupt protein– protein interactions of Grb2 and Crk family adaptors. Curr Pharm Design 12(5):529–548Google Scholar
  17. Forsyth JK, Lewis DA (2017) Mapping the consequences of impaired synaptic plasticity in schizophrenia through development: an integrative model for diverse clinical features. Trends Cognit Sci 21(10):760–778. Google Scholar
  18. Fukunaga K, Miyamoto E (1998) Role of MAP kinase in neurons. Mol Neurobiol 16(1):79–95. Google Scholar
  19. Gale NW, Kaplan S, Lowenstein EJ, Schlessinger J, Bar-Sagi D (1993) Grb2 mediates the EGF-dependent activation of guanine nucleotide exchange on Ras. Nature 363(6424):88–92. Google Scholar
  20. Ghaemi SN (2006) Paradigms of psychiatry: eclecticism and its discontents. Curr Opin Psychiat 19(6):619–624. Google Scholar
  21. Guo L, Yeh ML, Cuzon Carlson VC, Johnson-Venkatesh EM, Yeh HH (2012) Nerve growth factor in the hippocamposeptal system: evidence for activity-dependent anterograde delivery and modulation of synaptic activity. J Neurosci 32(22):7701–7710. Google Scholar
  22. Guo W, Nagappan G, Lu B (2018a) Differential effects of transient and sustained activation of BDNF-TrkB signaling. Dev Neurobiol 78(7):647–659. Google Scholar
  23. Guo X, Yang J, Huang J, Chen Z, Wu X, Zhu L, Huang G, Long J, Su L (2018b) Influence of CTNNB1 rs2953 polymorphism on schizophrenia susceptibility in Chinese Han population through modifying miR-485 binding to CTNNB1. Genes, brain, and behavior:e12524.
  24. Hou Y, Liang W, Zhang J, Li Q, Ou H, Wang Z, Li S, Huang X, Zhao C (2018) Schizophrenia-associated rs4702 G allele-specific downregulation of FURIN expression by miR-338-3p reduces BDNF production. Schizophr Res 199:176–180. Google Scholar
  25. Ikeda M, Hikita T, Taya S, Uraguchi-Asaki J, Toyo-oka K, Wynshaw-Boris A, Ujike H, Inada T, Takao K, Miyakawa T, Ozaki N, Kaibuchi K, Iwata N (2008) Identification of YWHAE, a gene encoding 14-3-3epsilon, as a possible susceptibility gene for schizophrenia. Hum Mol Genet17(20):3212–3222. Google Scholar
  26. Insel TR (2010) Rethinking schizophrenia. Nature 468(7321):187–193. Google Scholar
  27. Iritani S, Niizato K, Nawa H, Ikeda K, Emson PC (2003) Immunohistochemical study of brain-derived neurotrophic factor and its receptor, TrkB, in the hippocampal formation of schizophrenic brains. Progress Neuro-psychopharmacol Biol Psychiat 27(5):801–807. Google Scholar
  28. Isaev NK, Stelmashook EV, Genrikhs EE (2017) Role of nerve growth factor in plasticity of forebrain cholinergic neurons. Biochem Biokhim 82(3):291–300. Google Scholar
  29. Jablensky A, Sartorius N, Korten A, Ernberg G, Anker M, Cooper JE, Day R (1987) Incidence worldwide of schizophrenia. Br J Psychiat 151:408–409Google Scholar
  30. Jang IK, Zhang J, Gu H (2009) Grb2, a simple adapter with complex roles in lymphocyte development, function, and signaling. Immunol Rev 232(1):150–159. Google Scholar
  31. Kale A, Joshi S, Pillai A, Naphade N, Raju M, Nasrallah H, Mahadik SP (2009) Reduced cerebrospinal fluid and plasma nerve growth factor in drug-naive psychotic patients. Schizophr Res 115(2–3):209–214. Google Scholar
  32. Klesse LJ, Parada LF (1999) Trks: signal transduction and intracellular pathways. Microsc Res Tech 45 (4–5):210–216.;2-F Google Scholar
  33. Kudlek Mikulic S, Mihaljevic-Peles A, Sagud M, Bajs Janovic M, Ganoci L, Grubisin J, Kuzman Rojnic M, Vuksan Cusa B, Bradas Z, Bozina N (2017) Brain-derived neurotrophic factor serum and plasma levels in the treatment of acute schizophrenia with olanzapine or risperidone: 6-week prospective study. Nord J Psychiat 71(7):513–520. Google Scholar
  34. Kumar A, Pareek V, Faiq MA, Kumar P, Raza K, Prasoon P, Dantham S, Mochan S (2017) Regulatory role of NGFs in neurocognitive functions. Rev Neurosci 28(6):649–673. Google Scholar
  35. Kyosseva SV (2004) The role of the extracellular signal-regulated kinase pathway in cerebellar abnormalities in schizophrenia. Cerebellum 3(2):94–99. Google Scholar
  36. Kyosseva SV, Elbein AD, Griffin WS, Mrak RE, Lyon M, Karson CN (1999) Mitogen-activated protein kinases in schizophrenia. Biol Psychiat 46(5):689–696Google Scholar
  37. Law CL, Ewings MK, Chaudhary PM, Solow SA, Yun TJ, Marshall AJ, Hood L, Clark EA (1999) GrpL, a Grb2-related adaptor protein, interacts with SLP-76 to regulate nuclear factor of activated T cell activation. J Exp Med 189(8):1243–1253Google Scholar
  38. Libman-Sokolowska M, Drozdowicz E, Nasierowski T (2015) BDNF as a biomarker in the course and treatment of schizophrenia. Psychiatria polska 49(6):1149–1158. Google Scholar
  39. Lichtenstein P, Yip BH, Bjork C, Pawitan Y, Cannon TD, Sullivan PF, Hultman CM (2009) Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study. Lancet 373(9659):234–239. Google Scholar
  40. Lindberg D, Shan D, Ayers-Ringler J, Oliveros A, Benitez J, Prieto M, McCullumsmith R, Choi DS (2015) Purinergic signaling and energy homeostasis in psychiatric disorders. Curr Mol Med 15(3):275–295Google Scholar
  41. Long J, Huang G, Liang W, Liang B, Chen Q, Xie J, Jiang J, Su L (2014) The prevalence of schizophrenia in mainland China: evidence from epidemiological surveys. Acta Psychiatr Scand 130(4):244–256. Google Scholar
  42. Lowenstein EJ, Daly RJ, Batzer AG, Li W, Margolis B, Lammers R, Ullrich A, Skolnik EY, Bar-Sagi D, Schlessinger J (1992) The SH2 and SH3 domain-containing protein GRB2 links receptor tyrosine kinases to ras signaling. Cell 70(3):431–442Google Scholar
  43. Ma L, Huang YZ, Pitcher GM, Valtschanoff JG, Ma YH, Feng LY, Lu B, Xiong WC, Salter MW, Weinberg RJ, Mei L (2003) Ligand-dependent recruitment of the ErbB4 signaling complex into neuronal lipid rafts. J Neurosci 23(8):3164–3175Google Scholar
  44. Mahata SK, Mahata M, Wu H, Parmer RJ, O’Connor DT (1999) Neurotrophin activation of catecholamine storage vesicle protein gene expression: signaling to chromogranin a biosynthesis. Neuroscience 88(2):405–424Google Scholar
  45. Martinotti G, Di Iorio G, Marini S, Ricci V, De Berardis D, Di Giannantonio M (2012) Nerve growth factor and brain-derived neurotrophic factor concentrations in schizophrenia: a review. J Biol Regul Homeost Agents 26(3):347–356Google Scholar
  46. Mazzucchelli C, Brambilla R (2000) Ras-related and MAPK signalling in neuronal plasticity and memory formation. Cell Mol Life Sci 57(4):604–611. Google Scholar
  47. Misiak B, Stramecki F, Gaweda L, Prochwicz K, Sasiadek MM, Moustafa AA, Frydecka D (2018) Interactions between variation in candidate genes and environmental factors in the etiology of schizophrenia and bipolar disorder: a systematic review. Mol Neurobiol 55(6):5075–5100. Google Scholar
  48. Nanou E, Catterall WA (2018) Calcium channels, synaptic plasticity, and neuropsychiatric disease. Neuron 98(3):466–481. Google Scholar
  49. Negron-Oyarzo I, Lara-Vasquez A, Palacios-Garcia I, Fuentealba P, Aboitiz F (2016) Schizophrenia and reelin: a model based on prenatal stress to study epigenetics, brain development and behavior. Biol Res 49:16. Google Scholar
  50. Nowakowska E, Kus K, Ratajczak P, Cichocki M, Wozniak A (2014) The influence of aripiprazole, olanzapine and enriched environment on depressant-like behavior, spatial memory dysfunction and hippocampal level of BDNF in prenatally stressed rats. Pharmacol Rep 66(3):404–411. Google Scholar
  51. Pasquinelli AE (2012) MicroRNAs and their targets: recognition, regulation and an emerging reciprocal relationship. Nat Rev Genet 13(4):271–282. Google Scholar
  52. Perala J, Suvisaari J, Saarni SI, Kuoppasalmi K, Isometsa E, Pirkola S, Partonen T, Tuulio-Henriksson A, Hintikka J, Kieseppa T, Harkanen T, Koskinen S, Lonnqvist J (2007) Lifetime prevalence of psychotic and bipolar I disorders in a general population. Arch Gen Psychiat 64(1):19–28. Google Scholar
  53. Pillai A (2008) Brain-derived neurotropic factor/TrkB signaling in the pathogenesis and novel pharmacotherapy of schizophrenia. Neuro-Signals 16(2–3):183–193. Google Scholar
  54. Pitts AF, Miller MW (2000) Expression of nerve growth factor, brain-derived neurotrophic factor, and neurotrophin-3 in the somatosensory cortex of the mature rat: coexpression with high-affinity neurotrophin receptors. J Comp Neurol 418(3):241–254Google Scholar
  55. Polushina T, Giddaluru S, Bettella F, Espeseth T, Lundervold AJ, Djurovic S, Cichon S, Hoffmann P, Nothen MM, Steen VM, Andreassen OA, Le Hellard S (2017) Analysis of the joint effect of SNPs to identify independent loci and allelic heterogeneity in schizophrenia GWAS data. Transl Psychiat 7(12):1289. Google Scholar
  56. Prata J, Santos SG, Almeida MI, Coelho R, Barbosa MA (2017) Bridging autism spectrum disorders and schizophrenia through inflammation and biomarkers-pre-clinical and clinical investigations. J Neuroinflamm 14(1):179. Google Scholar
  57. Qian X, Riccio A, Zhang Y, Ginty DD (1998) Identification and characterization of novel substrates of Trk receptors in developing neurons. Neuron 21(5):1017–1029Google Scholar
  58. Rossi M, Kilpinen H, Muona M, Surakka I, Ingle C, Lahtinen J, Hennah W, Ripatti S, Hovatta I (2014) Allele-specific regulation of DISC1 expression by miR-135b-5p. Eur J Hum Genet 22(6):840–843. Google Scholar
  59. Rudenko G (2017) Dynamic control of synaptic adhesion and organizing molecules in synaptic plasticity. Neural Plast 2017:6526151. Google Scholar
  60. Saravani R, Galavi HR, Lotfian Sargazi M (2017) Catechol-O-methyltransferase (COMT) gene (Val158Met) and brain-derived neurotropic factor (BDNF) (Val66Met) genes polymorphism in schizophrenia: a case-control study. Iran J Psychiat 12(4):265–270Google Scholar
  61. Schinder AF, Poo M (2000) The neurotrophin hypothesis for synaptic plasticity. Trends Neurosci 23(12):639–645Google Scholar
  62. Shi S, Leites C, He D, Schwartz D, Moy W, Shi J, Duan J (2014) MicroRNA-9 and microRNA-326 regulate human dopamine D2 receptor expression, and the microRNA-mediated expression regulation is altered by a genetic variant. J Biol Chem 289(19):13434–13444. Google Scholar
  63. Song M, Martinowich K, Lee FS (2017) BDNF at the synapse: why location matters. Mol Psychiat 22(10):1370–1375. Google Scholar
  64. Sorg BA, Berretta S, Blacktop JM, Fawcett JW, Kitagawa H, Kwok JC, Miquel M (2016) Casting a wide net: role of perineuronal nets in neural plasticity. J Neurosci 36(45):11459–11468. Google Scholar
  65. Steri M, Idda ML, Whalen MB, Orru V (2018) Genetic variants in mRNA untranslated regions. Wiley Interdiscip Rev RNA 9(4):e1474. Google Scholar
  66. Sullivan PF, Fan C, Perou CM (2006) Evaluating the comparability of gene expression in blood and brain. Am J Med Genet Part B 141B (3):261–268. Google Scholar
  67. Sun J, Wan C, Jia P, Fanous AH, Kendler KS, Riley BP, Zhao Z (2011) Application of systems biology approach identifies and validates GRB2 as a risk gene for schizophrenia in the Irish Case Control Study of Schizophrenia (ICCSS) sample. Schizophr Res 125(2–3):201–208. Google Scholar
  68. Sweatt JD (2001) The neuronal MAP kinase cascade: a biochemical signal integration system subserving synaptic plasticity and memory. J Neurochem 76(1):1–10Google Scholar
  69. Tandon R, Keshavan MS, Nasrallah HA (2008) Schizophrenia, “just the facts” what we know in 2008. 2. Epidemiology and etiology. Schizophr Res 102(1–3):1–18. Google Scholar
  70. Tang G (2005) siRNA and miRNA: an insight into RISCs. Trends Biochem Sci 30(2):106–114. Google Scholar
  71. Tups A, Stohr S, Helwig M, Barrett P, Krol E, Schachtner J, Mercer JG, Klingenspor M (2012) Seasonal leptin resistance is associated with impaired signalling via JAK2-STAT3 but not ERK, possibly mediated by reduced hypothalamic GRB2 protein. J Comp Physiol B 182(4):553–567. Google Scholar
  72. Wang X, Li T, Li M, Cao N, Han J (2016) The functional SOCS3 RS115785973 variant regulated by MiR-4308 promotes gastric cancer development in Chinese population. Cell Physiol Biochem 38 (5):1796–1802. Google Scholar
  73. Weickert CS, Hyde TM, Lipska BK, Herman MM, Weinberger DR, Kleinman JE (2003) Reduced brain-derived neurotrophic factor in prefrontal cortex of patients with schizophrenia. Mol Psychiat 8(6):592–610. Google Scholar
  74. Whiteford HA, Degenhardt L, Rehm J, Baxter AJ, Ferrari AJ, Erskine HE, Charlson FJ, Norman RE, Flaxman AD, Johns N, Burstein R, Murray CJ, Vos T (2013) Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010. Lancet 382(9904):1575–1586. Google Scholar
  75. Wu S, Zhang R, Nie F, Wang X, Jiang C, Liu M, Valenzuela RK, Liu W, Shi Y, Ma J (2016) MicroRNA-137 inhibits EFNB2 expression affected by a genetic variant and is expressed aberrantly in peripheral blood of schizophrenia patients. EBioMedicine 12:133–142. Google Scholar
  76. Yu D, Tolleson WH, Knox B, Jin Y, Guo L, Guo Y, Kadlubar SA, Ning B (2015) Modulation of ALDH5A1 and SLC22A7 by microRNA hsa-miR-29a-3p in human liver cells. Biochem Pharmacol 98(4):671–680. Google Scholar
  77. Yu H, Yan H, Wang L, Li J, Tan L, Deng W, Chen Q, Yang G, Zhang F, Lu T, Yang J, Li K, Lv L, Tan Q, Zhang H, Xiao X, Li M, Ma X, Yang F, Li L, Wang C, Li T, Zhang D, Yue W (2018) Five novel loci associated with antipsychotic treatment response in patients with schizophrenia: a genome-wide association study. Lancet Psychiat 5(4):327–338. Google Scholar
  78. Zakharyan R, Atshemyan S, Gevorgyan A, Boyajyan A (2014) Nerve growth factor and its receptor in schizophrenia. BBA Clin 1:24–29. Google Scholar
  79. Zeng D, He S, Yu S, Li G, Ma C, Wen Y, Shen Y, Yu Y, Li H (2018) Analysis of the association of MIR124-1 and its target gene RGS4 polymorphisms with major depressive disorder and antidepressant response. Neuropsychiatr Dis Treat 14:715–723. Google Scholar
  80. Zhang F, Xu Y, Shugart YY, Yue W, Qi G, Yuan G, Cheng Z, Yao J, Wang J, Wang G, Cao H, Guo W, Zhou Z, Wang Z, Tian L, Jin C, Yuan J, Liu C, Zhang D (2015) Converging evidence implicates the abnormal microRNA system in schizophrenia. Schizophr Bull 41(3):728–735. Google Scholar
  81. Zhang L, Cao XL, Wang SB, Zheng W, Ungvari GS, Ng CH, Zhong BL, Wang G, Xiang YT (2017) The prevalence of bipolar disorder in China: a meta-analysis. J Affect Disord 207:413–421. Google Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  1. 1.School of Public Health of Guangxi Medical UniversityNanningChina
  2. 2.The Guangxi Zhuang Autonomous Region Brain HospitalLiuzhouChina

Personalised recommendations